seed
Stage
1
Investors
About
Soligenix is a biopharmaceutical company developing and commercializing products to treat rare diseases and other unmet medical needs, focusing on biodefense, oncology, and inflammatory diseases.
Explore Soligenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.